Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Baduanjin Sequential Therapy on the Cardiac Function and Exercise Endurance in Patients With AMI and Reduced Ejection Fraction After Primary PCI

NCT05201274 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT05201274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05201274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Baduanjin Sequential Therapy on the Cardiac Function and Exercise Endurance in Patients With AMI and Reduced Ejection Fraction After Primary PCI
Lead sponsor
Shenyang Northern Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 11, 2021
Completion date
February 11, 2023
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ami